More hikes in raw material prices and freight costs would pressure Supor’s earnings, as they typically account for the bulk of the cost of sales. Supor has a healthy balance sheet with minimal net ...
Japan's Central Bank Keeps Rates Unchanged The Bank of Japan left its short-term policy rate unchanged Friday as it examines how the economy and markets are digesting its most recent interest-rate ...
Fuji Soft shares fell sharply on fading expectations of a bidding war after two key shareholders of the software developer agreed to KKR's tender offer. Warren Buffett's conglomerate unloaded another ...
Norway's central bank held its key policy rate at 4.5%, a level that is expected to remain unchanged until the end of the year as a weak krone continues to threaten efforts to bring inflation down.
The U.S. dollar weakened early Friday. A general mood of "risk on" is widely acknowledged as a "gently softer USD adds to the allure of risk assets," said Vishnu Varathan, head of Macro Research for ...
--Chinese authorities are considering allowing major cities including Shanghai and Beijing to relax home-purchasing restrictions for buyers who don't carry a local hukou, or residence permit, ...
The Japanese central bank maintained its target for the overnight call rate at 0.25% after raising it to that level in July. In March, the BOJ ended the world's last negative interest rate policy and ...
Nike said John Donahoe will retire as chief executive and from the board, and named his successor, Elliott Hill, who retired from the sneaker maker in 2020. Fuji Soft shares fell sharply on fading ...
In an environment where active fund managers are under assault for poor relative performance and high fees, we believe wide-moat T. Rowe Price is one of the better positioned US-based traditional ...
FedEx (FDX) said it expects "low-single-digit percentage" sales growth for its fiscal 2025, which is set to conclude around the end of May. That's a bit less optimistic than an earlier forecast for ...
The Federal Reserve's aggressive interest-rate cut this week could provide some breathing space to distressed companies, according to Howard Ehrenberg, a partner at law firm Greenspoon Marder's ...
Johnson & Johnson said the Food and Drug Administration approved its treatment of locally-advanced or metastatic non-small cell lung cancer for adults. The treatment, called Rybrevant, has been ...